General Information
Version
1.0
Revision date
2019-10-28
Product name
Catapresan tablets (finished product)
Product Synonyms
Catapresan® tablets 0.075 mg, 0.1 mg, 0.15 mg, 0.2 mg and 0.3 mg tablets, Catapres® tablets 0,1 mg, 0,2mg and 0,3 mg, Catapresan® 2.5 mg/plaster, 5.0 mg/plaster, 7.5 mg/plaster, Catapresan® capsules, Dixarit®tablets, Catapres® capsules, Atensina® tablets with API: Clonidine hydrochloride
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user on use
Emergency telephone
+15159554661
Icons in SDS
Company Information
company name
Boehringer Ingelheim Vetmedica
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H332
Hazard statements
Code
Statements
H332
Harmful if inhaled
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning
Hazard statements
H332 Harmful if inhaled.
Prevention
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P271 Use only outdoors or in a well-ventilated area.
Response
P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell.
Hazardous Ingredients
Clonidine hydrochloride
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. The pharmacological effect of the medicament has to be considered (see package leaflet). This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity , Category 4 H332: Harmful if inhaled.
